Trump FDA Revamp Could Fast-Track Charlie's 678 Flavored Vape PMTAs
CHUC is trading near its 52-week low of $0.145 (5.5% above the low).
Summary
The Trump administration plans to streamline FDA authorization for flavored vapes, potentially clearing a path for Charlie's 678 pending PMTA applications. The company has been seeking approval since 2020 for tobacco-derived nicotine products and since 2022 for synthetic nicotine products. CEO Henry Sicignano says the current process has punished small businesses while illicit Chinese products flood the market. Charlie's sold 16 PACHA PMTA products in 2025 and retains 678 timely-filed assets, which management believes would become highly valuable under a streamlined pathway. The FDA is expected to announce the rule revision in coming days, with the company also planning to launch America's first flavored disposable vapes that cannot be activated by minors.
At the time of this announcement, CHUC was trading at $0.15 on OTC in the Trade & Services sector, with a market capitalization of approximately $42.9M. The 52-week trading range was $0.15 to $0.38. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.